KBC Group
ASPN icon

KBC Group’s Aspen Aerogels ASPN Stock Holding History

KBC Group’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,764
Closed -$49K – 1834
2024
Q3 		$49K Hold
1,764
– – ﹤0.01% 1712
2024
Q2 		$42K Buy
+1,764
New +$41.4K ﹤0.01% 1708

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KBC Group's ASPN Position: Q4 2024 in Review

KBC Group sold out of Aspen Aerogels (ASPN) in Q4 2024, closing a stake of 1,764 shares — an estimated $49K sold.

KBC Group first reported a position in ASPN in Q2 2024 and held it in 2 quarters. The position peaked at $49K in Q3 2024. 231 funds tracked by Wall St. Rank hold ASPN as of Q4 2024.

  • KBC Group reported no remaining Aspen Aerogels position as of Q4 2024 after selling out during the quarter.
  • KBC Group sold 1,764 Aspen Aerogels shares in Q4 2024, an estimated $49K.
  • KBC Group first reported a position in Aspen Aerogels in Q2 2024 and held it in 2 quarters.
  • KBC Group's Aspen Aerogels position peaked at $49K in Q3 2024.
  • 231 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2024.

Based on KBC Group's 13F filing for Q4 2024, filed 22 Jan 2025.